Leukotriene receptors

Clinical Reviews in Allergy and Immunology

Volumn 17, Issue 1-2, 1999, Pages 179-191

  Dahlén, Sven Erik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 METHOXY 4 [(PHENYLSULFONYLAMINO)CARBONYL]BENZYL] 1H INDAZOLE 6 CARBAMIC ACID CYCLOPENTYL ESTER; 2 [2 PROPYL 3 [3 [2 ETHYL 4 (4 FLUOROPHENYL) 5 HYDROXYPHENOXY]PROPOXY]PHENOXY]BENZOIC ACID; 2 [4 [2 (5 TETRAZOLYLMETHYL)BENZYLOXY]PHENOXYMETHYL]QUINOLINE; 3 [(2 CARBOXYETHYL)THIO] 3 [2 (8 PHENYLOCTYL)PHENYL]PROPIONIC ACID; 4 (4 CARBOXYPHENYLTHIO) 7 [4 (4 PHENOXYBUTOXY)PHENYL] 5 HEPTENOIC ACID; 6 (4 CARBOXYPHENYLTHIO) 5 HYDROXY 7,9,11,14 ICOSATETRAENOIC ACID; 7 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY) 2 HYDROXYPROPOXY] 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID; CGP 45715; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PEPTIDOLEUKOTRIENE; POBILUKAST; PRANLUKAST; TOMELUKAST; UNCLASSIFIED DRUG; VERLUKAST; ZAFIRLUKAST;

ASTHMA; BLOOD VESSEL REACTIVITY; BRONCHOSPASM; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG EFFECT; GENETIC TRANSCRIPTION; HEART MUSCLE CONTRACTILITY; HUMAN; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; MUCUS SECRETION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RECEPTOR BINDING; REVIEW; SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 0032809697     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737603     Document Type: Review

References (82)

1. 4 from human leukocytes. FEBS Lett 1981;130:107-112.
2. 4 in guinea pig lung in vitro. Br J Pharmacol 1982;77:267-275.
3. 4) on the guinea-pig lung. Prostagl Leuko Med 1982;8:157-170.
4. 4, a potent chemokinetic and aggregating substance released from polymorpho-nuclear leukocytes. Nature 1980;286:264-265.
5. Dahlén S-E, Björk J, Hedqvist P, Arfors K-E, Hammarström S, Lindgren JÅ, Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981;78:3887-3891.
6. 4: An inflammatory mediator in vivo. Prostaglandins 1981;22:213-222.
7. 4 induces extravasation and migration of polymorphonuclear leukocytes in vivo. Acta Physiol Scand 1982;116:105-108.
8. Smith MJH, Ford-Hutchinson AW, Bray MA. Leukotriene B: A potential mediator of inflammation. J Pharm Pharmacol 1980,32:517,518.
9. Sehmi R, Wardlaw AJ, Cromwell O, Kurihawa K, Waltman P, Kay AB. Interleukin-5 selectively enhances the chemotactic response of eosinophis obtained from normal but not eosinophilic subjects. Blood 1992;79:2952-2959.
10. 4 induces interleukin-5 generation from human T lymphocytes. Eur J Immunol 1993,23:2392-2398.
11. 4-A stereospecific stimulator for release of lysosomal enzymes from neutro-phils. FEBS Lett 1981;130:14-17.
12. 4. J Pharm Pharmacol 1981;33:616-618.
13. 4 on CD23 expression in B-lymphocytes. J Immunol 1989;143:1996-2000.
14. 4 enhances IL 4-induced IgE production from normal human lymphocytes. Cell Immunol 1994;156:124-134.
15. 4 pathway to inflammation control. Nature 1996;384:39-43.
16. Serhan CN. Signalling the fat controller. Nature 1996;384:23,24.
17. Coleman RA, Eglen RM, Jones RL, Narumiya S, Shimizu T, Smith WL, Dahlën S-E, Drazen JM, Gardiner PJ, Jackson WT, Jones TR, Krell RD, Nicosia S. Prostanoid and leukotrienic receptors: A progress report from the IUPHAR working parties on classification and nomenclature, In: Samuelsson B, Ramwell PW, Paoletti R, Folco F, Granström E, Nicosia S, eds. Advanced Prostaglandin, Thromboxane, and Leukotriene Research. Vol 23, 1994, pp. 283-285.
18. 4 to a receptoron human polymorphonuclear leukocytes. J Exp Med 1983;157:628-632.
19. 4 binding to human neutro-phils. Prostaglandins 1984,28:837-845.
20. Goldman DW, Chang FH, Gifford LA, Goetzl EJ, Bourne HR. Pertussis toxin inhibition of chemotactic factor induced calcium mobilization and function in human polymorphonuclear leukocytes. J Exp Med 1985;162:145-156.
21. 4 receptor in sheep lung membranes. J Pharm Exp Ther 1990;265:841-847.
22. 4 from leukocyte membrane preparations by (12R)- and (12S)-hydroxyeicosatetraenoic acid. Biochem Biophys Acta 1987;917:406-410.
23. 4. Tetrahedron Lett 1988;29:143-146.
24. 4 receptor antagonist, LY293111, on allergen-induced responses in asthma. Thorax 1996;51:1178-1184.
25. 4 that mediates chemotaxis. Nature 1997;387:620-624.
26. Owman C, Nilsson C, Lolait, SJ. Cloning of cDNA encoding a putative chemoattractant receptor. Genomics 1996;37:187-194.
27. 4 and its I-oxidized metabolites. FEBS Lett 1981;136:141-148.
28. 4 to guinea pig lung membranes. Biochem Biophys Res Commun 1985;143:364-371.
29. Drazen JM, Austen KF, Lewis RA, Clark DA, Goto G, Corey EJ. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci USA 1980;77:4354-4358.
30. 4. Acta Physiol Scand 1980;110:331-333.
31. Dahlën S-E, Hedqvist P, Hammarström S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980;288:484-486.
32. Hanna CJ, Bach MK, Pare PD, Schellenberg RR. Slow reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle. Nature 1981;290:343,344.
33. 4 on isolated human airway smooth muscle. Can J Physiol Pharmacol 1982;60:638-643.
34. 4 cause extensive and widespread plasma extravasation in the guinea pig. Naunyn-Schmiedebergk's Arch Pharmacol 1985;330:136-141.
35. Gardiner PJ, Abram TS, Cuthbert NJ. Evidence for two leukotriene receptor types in the guinea-pig isolated ileum. Eur J Pharmacol 1990;182:291-299.
36. Weichman BM, Muccitelli RM, Osborn RR, Holden DA, Gleason JG, Wasserman MA. In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig. J Pharm Exp Ther 1982;222:202-208.
37. 4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide receptors. Proc Natl Acad Sci USA 1984;81:4922-4925.
38. 4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle in vitro. Br J Pharmacol 1991;104:859-866.
39. Buckner CK, Fedyna JS, Robertson JL, Will JA, England DM, Krell RD, Saban R. Examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea-pig trachea and human intralobar airways. J Pharm Exp Ther 1990;252:77-85.
40. 4. J Pharm Exp Ther 1986;237:558-562.
41. 4 on glycoprotein and lysozyme secretion by human bronchial mucosa. Prostaglandins 1982;25:155-170.
42. 4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982;126:449-451.
43. 4 on mucin release into the cat trachea in vivo and in vitro. Br J Pharmacol 1982;77:391-393.
44. 2 release by leukotrienes in isolated guinea pig hearts. Eur J Pharmacol 1981;73:357-361.
45. 4 on guinea-pig isolated hearts. Br J Pharmacol 1982;76:169-176.
46. 4. A potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science 1982;217:841-843.
47. 4. Effects on human and guinea-pig cardiac preparations in vitro. J Pharm Exp Ther 1982;221:235-241.
48. 4 causes granulocyte infiltration into asthmatic airways. Lancet 1993;341:989,990.
49. 4 and methacholine on sputum cell differentials in asthma. Am J Respir Crit Care Med 1977;155:1247-1253.
50. 4 receptor antagonist pranlukast or an interleukin-5 monoclonal antibody. Am J Repir Crit Care Med 1996;154:850-857.
51. Munoz NM, Douglas I, Mayer I, Herrnreiter A, Zhu X, Leff AR. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. Am J Respir Crit Care Med. 1997;155:1398-1403.
52. Peppelenbosch MP, Teretoolen LGJ, Hage WJ, de Laat SW. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 1993;74:565-575.
53. 4 in allergen-induced increases in airway smooth muscle in the rat. Am Rev Respir Dis 1993;148:413-417.
54. Augstein J, Farmer JB, Lee TB, Sheard P, Tattersall ML. Selective inhibitor of slow reacting substance of anaphylaxis. Nature New Biol 1973;245:215-217.
55. 4 receptors in smooth muscle. Life Sci 1982;31:577-581.
56. Krell RD, Tsai BS, Berdoulay A, Barone M, Giles RE. Heterogeneity of leukotriene receptors in the guinea-pig trachea. Prostaglandins 1983;25:171-178.
57. 4 receptor in guinea-pig trachea. J Pharm Exp Ther 1984;231:616-622.
58. 4-induced contractions of guinea-pig trachea. Br J Pharmacol 1987;91:179-188.
59. Morris HR, Taylor GW, Jones CM, Piper PJ, Samhoun MN, Tippins JR. Slowreacting substances (leukotrienes): Enzymes involved in their biosynthesis. Proc Natl Acad Sci USA 1982;79:4838-4842.
60. 4, and antigen in vitro. Am Rev Respir Dis 1992;146:923-929.
61. Labat C, Ortiz JL, Norel X, Gorenne I, Verkey J, Abram TS, Cuthbert NJ, Tudhope SR, Normann P, Gardiner PJ, Brink C. A second cysteinyl leukotriene receptor in human lung. J Pharm Exp Ther 1992;263:800-805.
62. Snyder DW, Krell RD. Pharmacology of peptide leukotrienes on ferret isolated airway smooth muscle. Prostaglandins 1986;32:89-200.
63. 4 in the guinea-pig ileum. Eur J Pharmacol 1996;317:107-113.
64. Tudhope SR, Cuthbert NJ, Abram TS, Jennings MA, Maxey RJ, Thompson AM, Norman P, Gardiner PJ. BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes. Eur J Pharmacol 1994;264:317-323.
65. Wikström-Jonsson E. Functional characterization of receptors for cysteinylleukotrienes in sheep trachealis muscle. Pulm Pharmacol Therapeut 1997;10:29-36.
66. Ortiz JL, Gorenne I, Cortijo J, Seller A, Labat C, Sarria B, Abram TS, Gardiner PJ, Morcillo E, Brink C. Leukotriene receptors on human pulmonary vascular endothelium. Br J Pharmacol 1995;115:1382-1386.
67. Agonist and antagonist activities of the leukotriene analogue BAY u9773 in guinea pig lung. Eur J Pharmacol 1998;357:203-211.
68. 4. Am J Physiol 1991;261:L164-L171.
69. 4 receptors. J Pharm Exp Ther 1989;248:581-588.
70. Hay DWP, Muccitelli RM, Wilson KA, Wasserman MA, Torphy TJ. Functional antagonism by salbutamol suggests differences in the relative efficacies and dissociation constants of the peptidoleukotrienes in guinea-pig trachea. J Pharmacol Exp Ther 1987;244:71-78.
71. Woods JW, Evans JF, Ethier D. 5-lipoxygenase and 5-lipoxygenase activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med 1993;178:1935-1946.
72. 2 to the nuclear fraction upon macrophage activation Biochem Biophys Res Commun 1993;196:147-153.
73. 4 and structurally related conjugates. J Biol Chem 1994;269:27,807-27,810.
74. 4 to membranes from guinea-pig lung: Regualtion by ions and guanine nucleotides. Life Sci 1983;33:645-653.
75. 4 receptor in guinea pig lung. Proc Natl Acad Sci USA 1983;80:7415-7420.
76. 4 receptors in adulat and fetal human lung. Biochem Pharmacol 1985;34:4311-4317.
77. 4 in membranes from guinea pig ileal longitudinal muscle. Prostaglandins 1984;27:483-494.
78. 4 in membranes from human lung. Biochem Pharmacol 1985;34:2831-2837.
79. 4 in human bronchi. J Pharmacol Exp Ther 1987;242:189-198.
80. 4-binding protein in rat liver cytosol as glutathione S transferase. J Biol Chem 1986;261:8540-8546.
81. 4 synthase. J Biol Chem 1996;271:22,203-25,210.
82. 4 acts indirectly. Acta Physiol Scand 1983;118:393-403.